Quantifying the effect of 3T MRI residual system and patient-induced susceptibility distortions on radiotherapy treatment planning for prostate cancer. 
Introduction
The use of data from magnetic resonance imaging (MRI) for radiation therapy (RT) planning is increasing. This is primarily due to MRI's superior soft tissue contrast compared with computed tomography (CT), leading to improved delineations. For prostate cancers, it results in better coverage of the target volume and rectal sparing (1, 2) . However, the full integration of a magnetic resonance (MR)-only RT has been hindered by geometric distortions in MRI and lack of electron density information for dose calculations as well as MR-based digitally reconstructed radiographs (3) . Recently the introduction of commercial products for MR-only treatment planning of the prostate is paving the way for clinical implementation of MR-only RT (4) . From a dosimetric point of view, excellent results have been achieved when using data from MRI instead of CT for dose calculations, with errors consistently below 2% (5-7). Fiducial gold markers visible on images from MRI have been reliably used for patient positioning (8) , and techniques for the reconstruction of MRI-based digitally reconstructed radiographs have been presented (9, 10) . There are, however, concerns about the potential problems associated with geometric distortions from the MRI system and the patient to be imaged (11, 12) . System-related distortions come from inhomogeneities in the static magnetic field (B 0 field) and nonlinearities in the gradient. These distortions increase in magnitude with increasing radial distance from the isocenter of the MRI scanner. There are vendor-supplied correction algorithms to minimize gradient field nonlinearity distortions. However, residual system-related distortions persist. Because of the different magnetic properties of the patient's anatomic tissues, the patient also introduces distortions due to magnetic susceptibility effects and chemical shift effects. These are larger on high-field MR systems but can be reduced by utilizing high-bandwidth (BW) sequences. However, increasing the BW results in reduced signal-tonoise ratio, a potential image quality concern in RT treatment planning for organ sites with low signals (13) .
There are several studies that have looked at the potential effects of MR geometric distortions on either MR-CT or MR-only RT treatment planning on anatomic sites such as the breast, brain, and prostate (5, (14) (15) (16) (17) (18) (19) (20) . Particularly, the study on the breast concluded that even at high BWs the dosimetric impact of system-and patient-induced distortion could be clinically unacceptable. For the prostate, a recent study by Gustafsson et al (20) on the effect of system-related distortions on treatment plans reported no clinical dose difference when using 3-dimensional (3D) correction in combination with a high-BW sequence. In addition, Sun et al (19) reported 0.01% differences between MR-and CT-based dose calculations using a pelvic phantom for distortion quantification. However, these investigations on the prostate did not account for patientinduced susceptibility effects. In this study, we aimed to quantify the effect of residual system-and patient-induced susceptibility distortions on treatment plans in an MR-only workflow for different imaging BWs and gradient readout directions (GRDs).
Methods and Materials
Phantom measurement of system-related distortions A positron emission tomography MR/GE Signa 3T (General Electric, Waukesha, WI) scanner was used in this study. We used a commercially manufactured phantom (Spectronic Medical, Helsingborg, Sweden) with a signalproducing volume of 350.7 Â 470 Â 450.7 mm 3 to measure residual system distortions. Susceptibility-induced distortions from the phantom have been reported to be negligible (20) . Axial MR images of the phantom were acquired using our clinical sequence for prostate cancer examinations. This is a T2-weighted fast spin-echo sequence with a repetition time of 1500 milliseconds, an echo time of 99 milliseconds, a 50-cm field of view (FoV), 2-mm slice thickness without spacing, a 512 Â 512 image matrix, and 227 slices. Multiple scans at BWs of 122, 244, and 488 Hz per pixel with anterior/posterior (A/P) and right/left (R/L) GRDs were obtained with the vendor-supplied 3D correction. The geometric center of the phantom was placed at the isocenter of the scanner for all measurements.
Simulation of patient-induced susceptibility distortions
A method proposed by Lundman et al (21) that estimates susceptibility values from the bulk conversion of CT Hounsfield units was used to simulate patient-induced susceptibility distortions from 17 prostate cancer patients. The simulation process has been integrated in the Medical Interactive Creative Environment (MICE Toolkit), an image data analysis tool as part of the Swedish gentle RT project (http://gentleradiotherapy.se). All patient CT images had an in-plane resolution in a range of (0.97 Â 0.97) to (1.097 Â 1.097) mm 2 and an image matrix of 512 Â 512, whereas the resolution for the MR images of the phantom was (0.98 Â 0.98) mm 2 . We used the same BW and GRD arrangements from the phantom measurements in the susceptibility simulations. However, distortions in millimeters were obtained by multiplying each patient's displacement map by his or her individual image pixel sizes (21) .
Accounting for marker-induced susceptibility distortions was beyond the scope of this study. Therefore, we removed streak artifacts around the intraprostatic fiducial markers on the CT images as well as marker-induced susceptibility effects on the distorted CT images by masking these areas with soft tissue during the simulation process, thereby excluding regions of unrealistic susceptibility-induced distortion data.
Creating the distorted CT
We added displacement vector fields from the phantommeasured residual system distortions and simulated patient-induced susceptibility distortions. This was used to deform the patient CT images using Bspline interpolation. A deform function in the MICE Toolkit, based on the Insight Segmentation and Registration Toolkit's WarpImageFilter, warped the CT images with the supplied displacement field to produce distorted CT images (dCT). Each vector in the displacement field represented the distance between a geometric point in the CT image space and its corresponding point in the dCT data. Contrary to previous studies that did not take patient-induced susceptibility effects into account, the delineated RT structures were also distorted instead of directly copied from the CT to the dCT images (20, 22) . Thus, for each of the 17 patient CTs, 6 distorted CT datasets were obtained on the basis of the different BW and gradient readout directions, as follows: (1) dCT datasets at BW of 122 Hz per pixel in the R/L gradient direction; (2) dCT datasets at BW of 122 Hz per pixel in the A/P gradient direction; (3) dCT datasets at BW of 244 Hz per pixel in the R/L gradient direction; (4) dCT datasets at BW of 244 Hz per pixel in the A/P gradient direction; (5) dCT datasets at BW of 488 Hz per pixel in the R/L gradient direction; and (6) dCT datasets at BW of 488 Hz per pixel in the A/P gradient direction.
To eliminate unnecessary deformations as a result of distortion data from the peripherals of the phantom as well as simulate clinical scan conditions, the displacement fields were translated and resampled to match each patient's coordinates. Figure 1 shows the study workflow.
Treatment planning
Oncentra External Beam version 4.5 (Elekta, Stockholm, Sweden) was used for all optimizations and dose calculations. Dual arc volumetric modulated arc therapy (VMAT)eoptimized treatment plans were initially generated for all dCT images. We utilized 2 15-MV fields with a start angle of 178
, an arc length of 356 , and a 2 gantry spacing. The optimized field arrangements were transferred to the CT data (ie, the undistorted anatomy), and a "true" dose distribution was calculated. To isolate the effect of distortions on treatment plans, no further optimization was done during the calculation of the true dose distribution on the corresponding CT datasets. All patients had a prescribed absolute dose of 77 Gy in 35 fractions normalized to the planning target volume (PTV) and an integrated dose boost of 84 Gy for 6 patients with visible dominant lesions. The treatment isocenter was placed at the center of the PTV. A clinical target volume (CTV) to PTV margin of 7 mm, based on our clinical protocol, was used. In all, 204 (6 Â 17 optimized dCT and 6 Â 17 patient CT) treatment plans were calculated using a pencil beam algorithm with inhomogeneity correction. Table 1 shows the volumetric modulated arc therapy optimization objectives.
The clinical doseevolume acceptance priority criteria in order of descending importance used in this study were as follows:
Minimum dose to the CTV (CTV D min ) should be !95% of the prescribed dose (73 Gy). The 95% isodose (V 95% ) should cover at least 95% of the PTV. Volume -Number -2017 Impact of geometric distortions in MR-only RT Less than 15% of the outlined rectal volume should receive more than 90% of the prescribed dose (V 90% ). The "near minimum dose" to PTV (D 98% ) should be !90% of the prescribed dose (70 Gy).
Statistical analysis: equivalence testing
All plans were compared on the basis of the minimum dose to the CTV, V 95% , and D 98% of the PTV, as well as the V 90% of the rectum using the pairwise 1 2-sided equivalence test (TOST-P) (23). The null (H 0 ) and alternative (H 1 ) hypotheses are:
where (Àd, d) is the equivalent interval (the clinically acceptable difference) between the 2 treatment plans, and y 1 and y 2 are the mean of the measured parameters. Using TOST-P, equivalence was established at an alpha level (a) of 0.5% if the (1 À 2a)% confidence interval for the difference between the mean measured values of dCT and CT plans were found within (Àd, d). We chose d values of (À0.5, 0.5) Gy for dose differences and (À0.5, 0.5)% for percentage volume differences. All TOST-P calculations were done in NCSS 11.0.9 (NCSS, Kaysville, UT).
Results

Distortion quantification
The mean residual system distortions within a radial distance of up to 25 cm (50-cm FoV) in the R/L readout were 3.16, 2.22, and 2.02 mm for BWs of 122, 244, and 488 Hz per pixel. The corresponding distortions in the A/P readout were 3.19, 2.52, and 2.08 mm, respectively. The phantom extended farther in the A/P than in the R/L direction, leading to the slightly higher distortions recorded in the A/P gradient readout. Susceptibility effects resulted in maximum shifts of 5.8, 2.9, and 1.5 mm at the BWs used. The extent and location of distortions from the scanner and the patient's own anatomy are shown in Figure 2 . This was obtained when distortion maps from patient-induced susceptibility and system-related effects were overlaid on a representative CT image. An estimation of geometric shifts occurring at some anatomic sites because of distortions was obtained when displacement fields from the residual system distortions and patient-induced susceptibility effects were masked with the contours of some delineated structures. The plot displayed in Figure 3 shows the shifts occurring within the contours of the bladder, the femoral heads, PTV, and the rectum at our investigated BWs. These are the average shifts for all studied subjects.
Dosimetric evaluation
For the PTV, all plans were acceptable: the 95% isodose (PTV V 95% ) covered mean volumes of 99.9% AE 0.1% on dCT and 99.8% AE 0.1% on CT, with a maximum mean difference of 0.1% AE 0.22% across all patients. The mean dose at the isocenter for all patients was 76.5 AE 0.3 Gy and 76.4 AE 0.3 Gy for dCT and CT plans, respectively. The maximum dose difference decreased with increasing BW in the R/L direction, whereas it remained almost the same in the A/P direction. The mean percentage dose differences at the isocenter between distorted and undistorted treatment plans are shown in Table 2 . The dose distribution in the transverse plane for a representative patient at the isocenter between dCT and CT treatment plans, as well as the dose difference map, is given in Figure 4 . Table 3 
Discussions
This study investigated the dosimetric impact of geometric distortions on MRI-based prostate treatment plans. Previous investigations have shown that residual system distortions have a small impact on prostate dosimetry (19, 20, 24) . Our results show that patient-induced susceptibility distortions are larger than the system-specific distortions for the investigated BWs and FoVs. It might therefore not be sufficient to only refer to phantom-based distortion measurements when claiming adequate geometric accuracy for RT purposes. However, using a sufficient BW sequence the dosimetric impact is still within the 3% to 5% overall accuracy required for dose delivery and therefore may be considered acceptable for RT purposes (25) . Among the structures investigated, the femoral heads were the most sensitive to system-related distortions, whereas the prostate was the least affected, as shown in Figure 3 . Because the magnitude of system distortions increases with growing radial distance from the scanner's isocenter, treatment plans for target volumes situated in the peripheral parts of the FoV, such as breast carcinomas, thoracic wall, and abdominal soft tissue sarcomas, may be more affected by system-related distortions (7, 14) . For the same reason, distortions to the patient external contours might also be larger for larger patients.
Both system-specific and susceptibility-induced distortions are reduced with increasing BW. The results show that increasing the BW was relevant in reducing patientinduced susceptibility shifts compared with system distortions by a factor of 2, as can be seen in Figure 3 . The reduction in system-specific distortions is probably related to the reduced impact of inherent B 0 inhomogeneity and the small susceptibility effects caused by the phantom (20) . A benefit of using simulations and not direct measurements to estimate the patient-induced susceptibility effect is that contributions from inherent B 0 inhomogeneity are not counted twice when adding the system-and patient-specific distortions. It has been previously described that susceptibility effects generate field perturbations of up to AE10 ppm at 3T (26) , corresponding to calculated shifts of up to 6 pixels, which are in line with our results. On the basis of the results of this study, we recommend a BW of 440 Hz per pixel for 3T scanners, corresponding to 440 Hz/mm using 1 Â 1-mm Table 3 Equivalence test results between distorted and undistorted dose distributions based on the doseevolume criteria within an equivalence interval of (À0.5, 0.5) Gy for difference in dose and (À0.5, 0.5)% for difference in percentage volumes voxels in plane for prostate examinations in an RT context. At this BW, the water/fat shift is 1 voxel, and the distortions due to susceptibility effects will approximate to the same size as the system-specific distortions. Increasing BW beyond the recommended value would further decrease distortions, but the reduction in signal-to-noise ratio would limit its clinical applicability. It is worth noting that keeping the same BW per pixel while doubling the pixel size will also double the distortions. The use of vendor-supplied distortion correction algorithms only reduces system-related distortions but not patient-induced distortions. Because our results show that patient-induced susceptibility effects were larger, utilizing correction algorithms to reduce these distortions in an MR-only workflow could be useful. Suggested methods such as B 0 mapping (27) (28) (29) and reversed read-out gradient polarity (13) are currently to our knowledge not provided for routine clinical use from the major vendors and were not modeled in the present study. Intraprostatic fiducial markers introduce distortions in MR images due to the different magnetic properties between the markers and soft tissues. These distortions are, however, local and result in deviations of <1 mm (8) .
We found a relative dose difference at the PTV of <0.5%. This is within the findings from earlier studies by Petersch et al (24) and Mah et al (30) , who reported a dose difference of <1% between corrected MR and CT plans. Gustafsson et al (20) used a similar method to generate distorted CT using displacement maps from system-related distortions and found a mean percentage dose difference of 0.02%. This lower value compared with our results might be because patient-induced susceptibility distortions were not quantified.
In an MR-only workflow, structures will be drawn on the basis of MR images. Therefore, by distorting the RT structures in this study, any shifts in the images caused by MR distortions would also be reflected in the delineated contours. Chen et al (22) reported large discrepancies for some patients when the CT contours were directly transferred to the MR images for treatment planning.
The patient within the scanner introduces distortions due to susceptibility effects as well as chemical shift effect. Chemical shift effects due to the difference in resonance frequencies between water and fat molecules (440 Hz at 3T) were not included in this study. On the basis of the BWs used in this study, calculated shifts of up to 3.6, 1.8, and 0.9 pixels could be attributed to chemical shift distortions. We did not take into account potential susceptibility-induced distortions introduced by the phantom, though it has been reported to be <0.5 mm (20) . Patients with hip implants were also not included in this study. However, our simulation method can be used to estimate susceptibility-induced effects if their geometry and susceptibility values are known.
Conclusion
By combining measured residual system-specific distortions after 3D correction and simulated patient-induced distortions for spin-echoebased sequences, we found minimal effect of distortions on prostate cancer treatment plans in an MR-only workflow. The magnitude of susceptibility-related distortions in this study was larger than system-specific distortions, even with a BW of 488 Hz per pixel in a 3T scanner. With the increasing use of MR scanners with high field strengths, incorporating methods to correct patient-induced susceptibility effects could mitigate their effect on treatment plans in an MR-only RT.
